TEVA

#394
Teva Pharmaceutical Industries Limited American Depositary Shares
30.9650 USD
+0.47%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
30.9150
31.0000
年范围
19.0100
37.3400
日变化
+0.47%
每月变动
+6.67%
6个月变化
+62.08%
年变化
+62.08%
前一天收盘价
30.8200
开盘价
30.9200
买价
卖价
最低价
30.9150
High
31.0000
交易量
194
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 35.604 B
  • Employee 33 K
  • Founded N/A
  • CEO Richard Francis
  • Website www.tevapharm.com
  • Headquarter Israel
  • FIGI BBG000C0CD58
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
25.79
市销率
2.1

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

新闻